ClearPoint Neuro, Inc. (NASDAQ: CLPT) reported Q4 EPS of ($0.68), $0.50 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $20.55 million versus the consensus estimate of $5.2 million.

For earnings history and earnings-related data on ClearPoint Neuro, Inc. (CLPT) click here.